PT. RICHMOND, Calif., Aug. 30 /PRNewswire/ -- Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company developing novel formulations of proven CNS agents, today announced that Glenn A. Oclassen, President and Chief Executive Officer, is scheduled to present at the Thomas Weisel Partners Healthcare Conference at the Four Season Hotel, Boston, MA, on Wednesday, September 5, 2007, at 9:45 a.m. ET.
About Transcept Pharmaceuticals
Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company developing novel formulations of proven CNS agents to provide meaningful new patient benefits. Transcept priority projects include the development of products for insomnia and dopamine associated psychiatric disorders. For more information, please visit http://www.transcept.com.
Transcept Pharmaceuticals, Inc. Michael Gill Director of Communications (510) 215-3575 The Ruth Group Investors / Media Stephanie Carrington / Jason Rando (646) 536-7017 / 7025 scarrington@theruthgroup.comjrando@theruthgroup.com
Transcept Pharmaceuticals, Inc.
CONTACT: Michael Gill, Director of Communications of TransceptPharmaceuticals, Inc., +1-510-215-3575; or Media, Stephanie Carrington,+1-646-536-7017, scarrington@theruthgroup.com, or Jason Rando,1-646-536-7025, jrando@theruthgroup.com, both of The Ruth Group, forTranscept Pharmaceuticals, Inc.
Web site: http://www.transoral.com/
